[isatrader]

Mmh... I see that you watched far more closer than me in this topic.

I just considered the classification given by several websites.

It's difficult, as for example the three public companies that I've found that are making Continuous glucose monitoring products are all in different sub sectors i.e.

ABT: Health Care / Pharmaceuticals
DXCM: Health Care / Medical Supplies
SENS: Health Care / Medical Equipment

And another direct competitor call Sano isn't publicly traded, but was invested in recently by fitbit. https://www.cnbc.com/2018/01/05/fitbit-i...apple.html

So it's a micro sector, which I'd call "Continuous glucose monitoring". So can only really be judged by the the individual stocks charts imo, as the broad sector charts aren't specific enough. So based on those, its showing good relative strength versus the market.